2022 American Transplant Congress

TOPIC: Clinical Science

Pre-Emptive Rituximab Use for Epstein-Barr Virus (EBV) Viremia in Cardiothoracic Solid Organ Transplant Recipients
B. Astorga, A. Loethen, L. Potter
Pre-Transplant Desensitization Utilizing Intravenous Immune-Globulin and Tocilizumab: A Single Center Experience
I. Moinuddin, M. Miles, S. Sterling, A. Brown, P. Kimball, G. Gupta
Pre-Transplant Evaluation of Patients Undergoing Combined Heart-Liver Transplantation and Correlation with Explant Pathology
A. Shingina¹, J. N. Menachem¹, S. Brown¹, I. A. Ziogas², W. K. Wu³, M. J. Izzy⁴, J. Liang¹, K. Washington¹, S. Alexopoulos⁵
Pre-Transplant Ex-Vivo Analysis of Kidney Vasculature and Perfusion Using Contrast Computed Tomography
A. Feizi¹, J. R. DiRito¹, M. Harris¹, J. C. Stendahl¹, S. Spindler¹, C. M. Edwards¹, T. Lysyy¹, S. Lee¹, N. Boutagy¹, A. Fehér¹, P. Yoo¹, S. A. Hosgood², D. C. Mulligan¹, M. L. Nicholson², A. J. Sinusas¹, D. J. Haakinson¹, G. T. Tietjen¹
Pre-Transplant Frailty Predicts Infection After Liver Transplant in a Multi-Center Study of Older Adults
M. Malinis¹, M. Abidi², E. Benamu², N. Jakharia³, N. Law⁴, R. Sigler⁴, R. Nog⁵, S. Olivier⁵, S. Taimur⁶, N. Theodoropoulos⁷, J. Schaenman⁸
Pre-Transplant Self-Report of Length of Sobriety is Not Significantly Related to Early Return to Alcohol Use Post Transplant
J. Esswein¹, A. Powell¹, H. Bruschwein², S. Weinland¹
Pre-Transplant Vaccine Induced SARS-CoV-2 Antibodies Decrease Following Induction Therapy for Kidney Transplantation
N. Barros¹, A. C. Ermel¹, A. Sharfuddin², W. Goggins³, J. Fridell²
Pre-Vaccine Antibodies Against Seasonal Betacoronaviruses Are Associated with Decreased Antibody Response to SARS-CoV-2 mRNA Vaccination in Solid Organ Transplant Recipients
A. Karaba¹, W. Zhou¹, T. Aytenfisu¹, T. S. Johnston¹, O. Akinde¹, Y. Eby¹, A. Abedon¹, J. Alejo¹, C. Qin¹, J. Garonzik-Wang², S. Klein¹, J. Bailey¹, A. Cox¹, J. Blankson¹, D. Segev¹, A. Tobian¹, W. Werbel¹
Prebiotic Supplementation In Kidney Transplant Recipients For Preventing Infections And Gastrointestinal Upset: A Randomized Controlled Feasibility Study
S. Chan¹, C. M. Hawley¹, E. M. Pascoe², C. Z. Cao², S. B. Campbell², K. L. Campbell³, R. S. Francis², R. Hale¹, N. M. Isbel⁴, M. Morrison⁵, D. W. Johnson²
Predicted Performance of Bayesian-Based Precision Dosing Software for Tacrolimus
A. Seghezzo¹, J. Kerr¹, A. Gupta², A. Ta², L. Powell², A. Feist³